[1]
Ansari Djafari, A., Javanmard, B., Razzaghi, M., Hojjati, S.A., Razzaghi, Z., Faraji, S., Rahavian, A. and Garoosi, M. 2023. Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Randomized Controlled Trial. Urology Journal. 20, 02 (Feb. 2023), 123–128. DOI:https://doi.org/10.22037/uj.v20i02.7194.